PepGen PEPG
NASDAQ PEPG
$3.11 -0.07 (-2.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

PepGen (PEPG) Assets (2021 - 2026)

PepGen (PEPG) posted Assets of $156.3 million for Q1 2026, down 10.13% sequentially from $173.9 million in Q4 2025, and up 22.69% YoY from $127.4 million in Q1 2025.

Analysis

PepGen (PEPG) Assets (2021 - 2026) Analysis & Trends

PepGen has reported Assets for 6 years, with the latest figure at $156.3 million in Q1 2026.

  • Quarterly Assets rose 22.69% year-over-year to $156.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $156.3 million (up 22.69% YoY) and the FY2025 annual result came in at $173.9 million, up 15.26% from the prior year.
  • Assets slipped to $156.3 million in Q1 2026 per PEPG's latest filing, from $173.9 million in the prior quarter.
  • Over five years, Assets peaked at $230.8 million in Q2 2022 and troughed at $102.2 million in Q2 2025.
  • A 5-year average of $173.6 million and a median of $173.9 million in 2025 frame the typical range for Assets.
  • The sharpest annual moves came in 2023 and 2025: Assets jumped 52.44% in 2023, then tumbled 47.16% in 2025.
  • Over 5 years, Assets stood at $217.4 million in 2022, then slumped by 34.21% to $143.1 million in 2023, then gained by 5.47% to $150.9 million in 2024, then advanced by 15.26% to $173.9 million in 2025, then decreased by 10.13% to $156.3 million in 2026.
  • According to Business Quant data, Assets over the past three periods registered $156.3 million, $173.9 million, and $190.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 27.42 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 41.73 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 10.03 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 10.96 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.32 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 9.18 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 5.56 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.82 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 2.10 Bn
10 PepGen 217.99 Mn 217.99 Mn - 141.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 141.40 Mn
Mar 31, 2026 156.30 Mn
Dec 31, 2025 173.91 Mn
Sep 30, 2025 190.06 Mn
Jun 30, 2025 102.24 Mn
Mar 31, 2025 127.39 Mn
Dec 31, 2024 150.88 Mn
Sep 30, 2024 170.23 Mn
Jun 30, 2024 193.51 Mn
Mar 31, 2024 207.00 Mn
Dec 31, 2023 143.05 Mn
Sep 30, 2023 164.27 Mn
Jun 30, 2023 182.09 Mn
Mar 31, 2023 201.04 Mn
Dec 31, 2022 217.44 Mn
Sep 30, 2022 208.46 Mn
Jun 30, 2022 230.80 Mn
Mar 31, 2022 131.88 Mn
Dec 31, 2021 143.64 Mn